相关实验视频

Updated: Sep 13, 2025

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

鉴定埃普斯坦-巴尔病毒核抗原1 (EBNA1) 特定的T细胞受体:针对针对EBV相关恶性瘤的免疫疗法的含义

Ying Liu¹, Yaqi Pan¹, Huirong Ding²

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Cellular immunology

|August 3, 2025

概括

这项研究表明,埃普斯坦-巴尔病毒核抗原1 (EBNA1) 特定的T细胞在TCR工程治疗中成功扩展. 这些功能性EBNA1特异性TCR-T细胞为治疗EBV相关癌症提供了有前途的方法,包括潜伏I.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
病毒学病毒学

背景情况:

爱斯坦-巴尔病毒核抗原1 (EBNA1) 在所有EBV潜伏类型中表达,使其成为T细胞治疗的关键标.
开发EBNA1特异性T细胞受体 (TCR) 工程T细胞对于治疗EBV相关的恶性瘤至关重要,但仍然具有挑战性,特别是对于潜伏性I.
使用TCR工程T细胞的采用细胞疗法有可能向由爱斯坦-巴尔病毒 (EBV) 驱动的癌症.

研究的目的:

确定准备和扩展EBNA1特异性TCR工程T细胞的可行性.
识别和分离EBNA1特异性T细胞受体 (TCRs),用于治疗.
评估工程T细胞与EBV感染细胞的功能.

主要方法:

使用EBNA1脉冲的自身树突细胞 (DCs) 刺激EBNA1特异性T细胞.
使用高通量单细胞TCR V(D) J测序来识别候选EBNA1特异性TCR.
工程T细胞的体外功能被评估与EBNA1表达标,如淋巴细胞细胞系 (LCLs) 和DCs.

主要成果:

取得了EBNA1特异性T细胞的成功扩张.
候选EBNA1特异性TCRs被分离出来,相应的基因序列被合成并引入T细胞.
工程T细胞表现出由自身LCL和DCs呈现的EBNA1的特定识别.

结论:

这项研究证实了扩大功能EBNA1特异性TCR-T细胞的可行性.
这些发现为开发针对所有与EBV相关的恶性瘤的TCR-T细胞疗法提供了基础.
这种方法适用于EBV潜伏期I,解决了癌症治疗的关键未满足需求.

关键词:

树突性细胞树突性细胞爱斯坦-巴尔病毒核抗原1核抗原1 淋巴细胞细胞系的细胞系.单细胞TCR测序的一种方式.T细胞受体的T细胞受体.

更多相关视频

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...